Pharmacological inhibition or congenital absence of MPO decreased post-ischemic fibrosis, reduced left ventricular dilation, and improved left ventricular function in animal models of myocardial infarction [8,9,10,11]. The gene discussed is MPO; the disease is myocardial infarction.